Otsuki, Y., Yamasaki, J., Suina, K., Okazaki, S., Koike, N., Saya, H., & Nagano, O. (2019). Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy. Cancer Sci.

Otsuki, Yuji, Juntaro Yamasaki, Kentaro Suina, Shogo Okazaki, Naoyoshi Koike, Hideyuki Saya, ja Osamu Nagano. "Vasodilator Oxyfedrine Inhibits Aldehyde Metabolism and Thereby Sensitizes Cancer Cells to XCT‐targeted Therapy." Cancer Sci 2019.

Otsuki, Yuji, et al. "Vasodilator Oxyfedrine Inhibits Aldehyde Metabolism and Thereby Sensitizes Cancer Cells to XCT‐targeted Therapy." Cancer Sci 2019.